Literature DB >> 31092415

Clinical Impact of Sarcopenia on Gastric Cancer.

Kazuya Kuwada1, Shinji Kuroda2,3, Satoru Kikuchi2,4, Ryuichi Yoshida2, Masahiko Nishizaki2, Shunsuke Kagawa2,4, Toshiyoshi Fujiwara2.   

Abstract

Sarcopenia is a complex syndrome defined by progressive and generalized loss of skeletal muscle mass and strength. Although sarcopenia is mainly associated with aging, cancer is also one of its causes. Sarcopenia is now drawing attention as a poor prognostic factor in cancer. In patients with gastric cancer associated with eating disorders that often leads to loss of weight and muscle, sarcopenia is particularly important. Its definition and method of assessment, however, vary between studies, thus these need to be standardized. Nevertheless, emerging evidence suggests that sarcopenia contributes independently to postoperative complications and overall survival in gastric cancer. Interventions preventing sarcopenia with targeted nutrition and exercise are currently explored. This review aims to provide an understanding of sarcopenia, emphasizing its importance in the management of gastric cancer. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Sarcopenia; chemotherapy; gastric cancer; intervention; review; surgery

Mesh:

Year:  2019        PMID: 31092415     DOI: 10.21873/anticanres.13340

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  16 in total

1.  The Analysis of Surgical Outcomes in Operable Gastric Cancer Patients Presenting With or Without Sarcopenia.

Authors:  Supratim Bhattacharyya; Padmalaya Devi; Prafulla Kumar Das; Subrat Samantara; Kunhi Mohammed Kp; Snehasis Pradhan; Muhammed Navas Nk
Journal:  Indian J Surg Oncol       Date:  2022-01-28

2.  CT-derived body composition measurements as predictors for neoadjuvant treatment tolerance and survival in gastroesophageal adenocarcinoma.

Authors:  Kyle J Lafata; Mustafa R Bashir; Mariana R DeFreitas; Amadu Toronka; Marybeth A Nedrud; Sarah Cubberley; Islam H Zaki; Brandon Konkel; Hope E Uronis; Manisha Palta; Dan G Blazer
Journal:  Abdom Radiol (NY)       Date:  2022-10-09

Review 3.  Clinical Impact of Sarcopenia on Cholangiocarcinoma.

Authors:  Suk-Pyo Shin; Dong-Hee Koh
Journal:  Life (Basel)       Date:  2022-05-30

4.  Advanced Age Is a Risk Factor for Recurrence After Resection in Stage II Colorectal Cancer.

Authors:  Kosuke Mima; Junji Kurashige; Nobutomo Miyanari; Atsushi Morito; Shinsei Yumoto; Takashi Matsumoto; Keisuke Kosumi; Mitsuhiro Inoue; Takao Mizumoto; Tatsuo Kubota; Hideo Baba
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

5.  Pectoralis Muscle Mass on Chest CT at Admission Predicts Prognosis in Patients with Pneumonia.

Authors:  Ryohsuke Yokosuka; Ryosuke Imai; Shosei Ro; Manabu Murakami; Kohei Okafuji; Atsushi Kitamura; Yutaka Tomishima; Torahiko Jinta; Naoki Nishimura; Tomohide Tamura; Osamu Takahashi
Journal:  Can Respir J       Date:  2021-12-06       Impact factor: 2.409

6.  Impact of skeletal muscle mass in patients with unresectable gastric cancer who received palliative first-line chemotherapy based on 5-fluorouracil.

Authors:  Tomoyuki Matsunaga; Hiroaki Saito; Wataru Miyauchi; Yuji Shishido; Kozo Miyatani; Masaki Morimoto; Yuki Murakami; Takehiko Hanaki; Kyoichi Kihara; Manabu Yamamoto; Naruo Tokuyasu; Shuichi Takano; Teruhisa Sakamoto; Toshimichi Hasegawa; Yoshiyuki Fujiwara
Journal:  BMC Cancer       Date:  2021-11-13       Impact factor: 4.430

7.  Analysis of the Occurrence of Diseases Following Gastrectomy for Early Gastric Cancer: a Nationwide Claims Study.

Authors:  Ho Seok Seo; Yewon Na; Jaehun Jung
Journal:  J Gastric Cancer       Date:  2021-10-01       Impact factor: 3.720

8.  Utility of monthly minodronate for osteoporosis after gastrectomy: Prospective multicenter randomized controlled trials.

Authors:  Masashi Hirota; Tsuyoshi Takahashi; Yurina Saito; Ryohei Kawabata; Rie Nakatsuka; Hiroshi Imamura; Masaaki Motoori; Yoichi Makari; Atsushi Takeno; Kentaro Kishi; Shinichi Adachi; Hiromichi Miyagaki; Yukinori Kurokawa; Makoto Yamasaki; Hidetoshi Eguchi; Yuichiro Doki
Journal:  Ann Gastroenterol Surg       Date:  2021-07-09

9.  Prognostic significance of sarcopenia in microsatellite-stable gastric cancer patients treated with programmed death-1 inhibitors.

Authors:  Yeun-Yoon Kim; Jeeyun Lee; Woo Kyoung Jeong; Seung Tae Kim; Jae-Hun Kim; Jung Yong Hong; Won Ki Kang; Kyoung-Mee Kim; Insuk Sohn; Dongil Choi
Journal:  Gastric Cancer       Date:  2020-09-24       Impact factor: 7.370

10.  Body mass index and skeletal muscle index are useful prognostic factors for overall survival after gastrectomy for gastric cancer: Retrospective cohort study.

Authors:  Eun Young Kim; Kyong Hwa Jun; Shinn Young Kim; Hyung Min Chin
Journal:  Medicine (Baltimore)       Date:  2020-11-20       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.